Research ArticleArticle
Adverse Effects of Doxorubicin and Its Metabolic Product on Cardiac RyR2 and SERCA2A
Amy D. Hanna, Alex Lam, Steffi Tham, Angela F. Dulhunty and Nicole A. Beard
Molecular Pharmacology October 2014, 86 (4) 438-449; DOI: https://doi.org/10.1124/mol.114.093849